We are proud to announce the Brazilian HIV Forum Educational series from 18 March till 22 March 2019!
The scientific content of this educational series is developed by leading world experts Mauro Schechter and Charles Boucher. The Educational series is a joint initiative with the Brazilian Infectious Diseases Society. The Educational series will provide independent scientific programs tailored to the needs of Brazilian HIV clinicians and allied healthcare professionals.
This special evening program will include plenary lectures and there is plenty of opportunity to interact with key experts in the field during Q&A and discussions! These meetings will take place on the following dates and cities, click on one of the below to register:
Antiretroviral therapy has resulted in immense reductions in morbidity and mortality in HIV infected individuals in Brazil as in many other countries. But optimal clinical implementation in routine care of antiretroviral drugs is a challenge due to the rapid pace at which new and improved compounds have been approved for use and are now available to HIV providers and patients in Brazil. Integrase inhibitors are no exception, and their optimal use presents a significant challenge to the busy clinician. Not only does this drug class differ significantly from older classes, the individual drugs of the class also differ greatly in a number of key characteristics (such as pharmacology and barrier to resistance). A wealth of clinically relevant data is presented at scientific meetings and published in the peer reviewed literature at a pace exceedingly difficult for the busy Brazilian practicing clinician to keep up with. In addition, treatment Guidelines reflecting these data and clinical experience are also being updated at a rapid pace.
To educate HIV healthcare professionals in Brazil on how to optimally use Integrase Inhibitors in daily clinical practice, we have developed a series of HIV Clinical Fora in several cities in Brazil. During the program the Brazilian clinicians can be informed and updated on relevant data and engage in dialogue with experts and colleagues in a concise, concentrated, and efficient manner.
Erasmus Medical Center,
Sheba Medical Center,
of Rio de Janeiro, Brazil
Sergio Cimerman, MD
Sociedade Brasileira de Infectologia (SBI),
Registration, Reception, Coffee
Welcome, Introduction and Goals
Basic Characteristics of Integrase Inhibitors
Resistance Characteristics of HIV Integrase Inhibitors
Roger Paredes, IrsiCaixa Foundation, Barcelona, Spain - São Paulo, Porte Alegre, Belo Horizonte, Salvador
Charles Boucher, Erasmus Medical Center, Rotterdam, the Netherlands - Rio de Janeiro
Safety and drug interactions
David Back, University of Liverpool, Liverpool, United Kingdom - São Paulo, Porte Alegre, Belo Horizonte, Salvador
Anton Pozniak, Chelsea and Westminster Hospital, London, United Kingdom - Rio de Janeiro
10:30pm End of Meeting
The use of Integrase Inhibitors: from guidelines to the real world
Anton Pozniak, Chelsea and Westminster Hospital, London, United Kingdom - SãoPaulo, Porte Alegre, Belo Horizonte, Salvador
Roger Paredes, IrsiCaixa Foundation, Barcelona, Spain - Rio de Janeiro
Clinical Case presentation
José Valdez Madruga - São Paulo
Eduardo Sprinz - Porto Alegre
Jorge Pinto - Belo Horizonte
Carlos Brites - Salvador
Márcia Rachid, Rio de Janeiro
Registration is free of charge for all healthcare practitioners*. A registration fee applies to other individuals.
*Healthcare practitioners are defined as professionals that provide any type of health care service to patients living with HIV. If you are not sure, please do not hesitate to contact us at email@example.com.
We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay in Brazil.
The accommodation information will be coming soon.
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent by e-mail after the workshop.
Conference materials can be obtained upon registration at the registration desk at the Conference Venue starting 7.00 PM depending on the date of the meeting.
The official conference language is Portuguese and English (with subtitle).
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
The meetings will take place in the following venues:
18 March 2018 | São Paulo – Hilton São Paulo Morumbi
19 March 2018 | Porto Alegre – Sheraton Porto Alegre Hotel
20 March 2018 | Belo Horizonte – Hilton Garden Inn Belo Horizonte
21 March 2018 | Salvador – WISH Hotel da Bahia
22 March 2018 | Rio de Janeiro – Hilton Rio de Janeiro Copacabana
Information on internet access in the venue will follow shortly.
Payment and procedure of on-line registration
Your registration is free of charge for all healthcare practitioners. You will get a confirmation of the registration within two weeks. If you did not received a confirmation, please contact the organizing secretariat email: firstname.lastname@example.org.
Photographs, audio and video recording
Photographs as well as audio and video recordings are not permitted at the official meeting sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations, will be posted on the workshop website (under Workshop Materials) as soon as possible after the workshop is finished, provided the speaker has given permission to do so.